Cathay Biotech Inc. (SHA:688065)

China · Delayed Price · Currency is CNY

42.16

-1.30 (-2.99%)

May 25, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biological Long-Chain Dibasic Acid	2.94B	-						-	-	849.62M
Bio-Based Polyamide	127.41M	-						-	-	2.61M
Others	57.84M	-						-	-	13.09M
Total	3.12B	-						-	-	865.31M

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	2.18B	-						667.57M	518.86M	257.90M
China Growth	-	-						28.66%	101.19%	-
Overseas	938.57M	-						957.92M	783.46M	607.41M
Overseas Growth	-	-						22.27%	28.98%	-
Total	3.12B	-						1.63B	1.30B	865.31M
Total Growth	-	-						24.82%	50.50%	-

Source: S&P Global Market Intelligence.